Willow Biosciences Inc. (WLLW.TO)

CAD 0.01

(0.0%)

Net Debt Summary of Willow Biosciences Inc.

  • Willow Biosciences Inc.'s latest annual net debt in 2023 was -989 Thousand CAD , up 90.44% from previous year.
  • Willow Biosciences Inc.'s latest quarterly net debt in 2024 Q2 was 646 Thousand CAD , up 189.56% from previous quarter.
  • Willow Biosciences Inc. reported annual net debt of -10.34 Million CAD in 2022, up 64.72% from previous year.
  • Willow Biosciences Inc. reported annual net debt of -29.31 Million CAD in 2021, down -95.11% from previous year.
  • Willow Biosciences Inc. reported quarterly net debt of 646 Thousand CAD for 2024 Q2, up 189.56% from previous quarter.
  • Willow Biosciences Inc. reported quarterly net debt of -4.46 Million CAD for 2023 Q2, up 55.18% from previous quarter.

Annual Net Debt Chart of Willow Biosciences Inc. (2023 - 1998)

Historical Annual Net Debt of Willow Biosciences Inc. (2023 - 1998)

Year Net Debt Net Debt Growth
2023 -989 Thousand CAD 90.44%
2022 -10.34 Million CAD 64.72%
2021 -29.31 Million CAD -95.11%
2020 -15.02 Million CAD 18.54%
2019 -18.44 Million CAD -4853.84%
2018 -372.34 Thousand CAD -302.86%
2017 -92.42 Thousand CAD -107.96%
2016 1.16 Million CAD 439.32%
2015 -342.33 Thousand CAD -801.52%
2014 -37.97 Thousand CAD -39.95%
2013 -27.13 Thousand CAD -109.56%
2012 283.71 Thousand CAD 708.26%
2011 -46.64 Thousand CAD 91.73%
2010 -563.89 Thousand CAD 22.16%
2009 -724.41 Thousand CAD -91.48%
2008 -378.31 Thousand CAD 37.19%
2007 -602.31 Thousand CAD -374.84%
2006 -126.84 Thousand CAD 45.57%
2005 -233.06 Thousand CAD -448092.31%
2004 -52.00 CAD 0.0%
2003 - CAD 100.0%
2002 -34.00 CAD 91.69%
2001 -409.00 CAD -219.53%
2000 -128.00 CAD 0.0%
1999 - CAD 0.0%
1998 - CAD 0.0%

Peer Net Debt Comparison of Willow Biosciences Inc.

Name Net Debt Net Debt Difference
Aurora Cannabis Inc. -8.64 Million CAD 88.564%
Avicanna Inc. 1.32 Million CAD 174.574%
Avant Brands Inc. 17.93 Million CAD 105.516%
Cardiol Therapeutics Inc. -34.77 Million CAD 97.156%
Crescita Therapeutics Inc. -8.13 Million CAD 87.837%
Knight Therapeutics Inc. 10.33 Million CAD 109.574%
MediPharm Labs Corp. -15.68 Million CAD 93.695%
OrganiGram Holdings Inc. -33.7 Million CAD 97.066%
Canopy Growth Corporation 512.87 Million CAD 100.193%
Auxly Cannabis Group Inc. 142.88 Million CAD 100.692%